Development Level

Tbio 7 | 11,651
Tclin 4 | 612
Tchem 3 | 1,388

IMPC Phenotype

decreased circulating bilirubi... 1 | 19
decreased circulating sodium l... 1 | 22
decreased fasted circulating g... 1 | 65
decreased grip strength 1 | 116
decreased neutrophil cell numb... 1 | 42
decreased red blood cell distr... 1 | 41
increased blood urea nitrogen ... 1 | 48
increased circulating HDL chol... 1 | 80
premature death 1 | 5
preweaning lethality, incomple... 1 | 499

Disease

Cancer 10 | 2,499
psoriasis 9 | 6,694
interstitial cystitis 7 | 2,312
lung carcinoma 7 | 2,843
Hypertension 6 | 396
atypical teratoid / rhabdoid tumor 6 | 5,112
breast carcinoma 6 | 1,638
glioblastoma 6 | 5,792
intraductal papillary-mucinous adenoma (IPMA) 6 | 2,955
invasive ductal carcinoma 6 | 2,951
medulloblastoma, large-cell 6 | 6,241
Hypersensitivity reaction type II disease 5 | 253
Liver Cirrhosis, Experimental 5 | 769
Multiple Sclerosis 5 | 540
active ulcerative colitis 5 | 764
adult high grade glioma 5 | 3,801
intraductal papillary-mucinous carcinoma (IPMC) 5 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 5 | 3,291
juvenile dermatomyositis 5 | 1,187
lung adenocarcinoma 5 | 2,716
lung cancer 5 | 4,740
malignant mesothelioma 5 | 3,232
pancreatic cancer 5 | 2,398
Breast cancer 4 | 3,578
Hepatitis C 4 | 94
Kidney disease 4 | 430
Lung disease 4 | 142
Pneumonia 4 | 174
Type 1 Diabetes Mellitus Treatment Adjunct 4 | 4
Type 2 Diabetes Mellitus Treatment Adjunct 4 | 7
active Crohn's disease 4 | 922
cutaneous lupus erythematosus 4 | 1,057
head and neck cancer and chronic obstructive pulmonary disease 4 | 239
sarcoidosis 4 | 370
tuberculosis 4 | 2,010
Alopecia areata 3 | 41
Arthritis 3 | 290
Carcinoma 3 | 11,493
Cerebrovascular disease 3 | 238
Cystitis, Interstitial 3 | 3
Dermatitis 3 | 157
Hypersensitivity 3 | 63
Inflammatory bowel disease 3 | 151
Malaria 3 | 160
Migraine 3 | 83
Phaeochromocytoma 3 | 20
Rheumatoid arthritis 3 | 1,191
Schizophrenia 3 | 1,160
colon cancer 3 | 1,478
diabetes mellitus 3 | 1,728
ductal carcinoma in situ 3 | 1,745
ependymoma 3 | 4,679
group 3 medulloblastoma 3 | 4,104
nasopharyngeal carcinoma 3 | 1,058
non-small cell lung cancer 3 | 2,890
osteosarcoma 3 | 7,950
ovarian cancer 3 | 8,520
Adenoma 2 | 167
Alzheimer's disease 2 | 658
Amyloidosis 2 | 67
Asthma 2 | 385
Autoimmune Diseases 2 | 67
Biliary cirrhosis 2 | 45
Bipolar Disorder 2 | 666
Brain Ischemia 2 | 110
Cerebrovascular accident 2 | 63
Coronary artery disease 2 | 268
Cushing's syndrome 2 | 48
Dermatitis, Atopic 2 | 37
Diarrhea 2 | 253
Encephalitis 2 | 64
Eye disease 2 | 62
Glomerulonephritis 2 | 46
Heart disease 2 | 306
Hepatitis 2 | 67
Human immunodeficiency virus infectious disease 2 | 138
Hypercalcemia 2 | 59
Hyperparathyroidism 2 | 48
Influenza 2 | 142
Lichen planus 2 | 16
Liver Cirrhosis, Biliary 2 | 33
Osteoporosis 2 | 363
Vascular disease 2 | 319
Weight Gain 2 | 100
adrenocortical carcinoma 2 | 1,428
astrocytic glioma 2 | 2,597
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 510
cystic fibrosis 2 | 1,696
dermatomyositis 2 | 966
gastric cancer 2 | 459
head and neck cancer 2 | 271
hepatocellular carcinoma 2 | 547
mucosa-associated lymphoid tissue lymphoma 2 | 484
non primary Sjogren syndrome sicca 2 | 891
non-small cell lung carcinoma 2 | 317
oligodendroglioma 2 | 2,850
pituitary cancer 2 | 1,972
posterior fossa group A ependymoma 2 | 468
primitive neuroectodermal tumor 2 | 3,035
ulcerative colitis 2 | 1,819

Tissue

Digestive Tract 14 | 17,369
Endocrine System 14 | 18,159
Liver and Pancreas 14 | 16,750
Nervous System 14 | 16,725
Skin and soft tissues 14 | 17,230
Urinary Tract 14 | 16,678
Blood and immune system 13 | 16,909
Female tissues 13 | 17,400
Male tissues 13 | 17,142
Respiratory system 13 | 16,393
Cardiovascular System 11 | 15,192

Target Family

Non-IDG 12 | 12,091
GPCR 2 | 408

GO Process

positive regulation of cAMP me... 14 | 14
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
C-X-C motif chemokine 10 CXCL10 Tbio Non-IDG -3.27118 1942.1 623
Platelet factor 4 PF4 Tbio Non-IDG -3.30967 2121.0 327
Calcitonin receptor CALCR Tclin GPCR -2.61142 364.5 0
C-X-C motif chemokine 9 CXCL9 Tbio Non-IDG -2.97954 923.8 413
C-X-C motif chemokine 11 CXCL11 Tbio Non-IDG -2.73499 520.2 403
Chromogranin-A CHGA Tbio Non-IDG -3.36997 2235.2 1399
C-X-C chemokine receptor type 3 CXCR3 Tchem GPCR -2.92733 849.1 650
ADM ADM Tbio Non-IDG -3.27504 1889.0 381
Calcitonin gene-related peptide 1 CALCA Tchem Non-IDG -3.70355 8831.3 1309
Islet amyloid polypeptide IAPP Tbio Non-IDG -3.20630 1751.6 330